Search
Products meeting the search criteria
Data Integrity and Privacy - Compliance with 21 CFR Part 11, SaaS/Cloud, EU GDPR in 2026
Overview: In 2026, data integrity and privacy risks don’t sit in one department—they show up ..
Date : 19th March 2026
Time : This Event is Over
Duration : 90 Mins
Prepare for FDA QMSR Inspections: 483 & Warning Letter Response
Overview: FDA inspections under the new QMSR can look and feel different—not just in what inv..
Date : 23rd February 2026
Time : This Event is Over and the Recorded Content is Available
Duration : 60 Mins
Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA in 2025
Overview: The U.S. Food and Drug Administration (FDA) plays a critical role in safeguarding pub..
Date : 27th June 2025
Time : This Event is Over and the Recorded Content is Available
Duration : 90 Mins
Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA in 2024
Overview: The U.S. Food and Drug Administration (FDA) plays a critical role in safeguarding p..
Date : 30th August 2024
Time : This Event is Over and the Recorded Content is Available
Duration : 90 Mins
Excel Spreadsheet in FDA Environment - Ensuring Data Integrity and 21 CFR Part 11 Compliance in 2024
Overview:The use of Excel in FDA-regulated environments extends beyond basic data organization and a..
Date : 15th May 2024
Time : This Event is Over
Duration : 90 Mins
Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA
Overview: FDA has substantial authority to oversee regulated companies and their operations.&n..
Date : 30th November 2022
Time : This Event is Over and the Recorded Content is Available
Duration : 90 Mins
The 6 Most Common Problems in FDA Software Validation and Verification in 2026
Overview: Software validation and verification remain common sources of compliance risk for F..
Date : 14th May 2026
Time : 1:00 PM Eastern Time / 10:00 AM Pacific Time
Duration : 75 Mins